Literature DB >> 26322825

Monobody-mediated alteration of enzyme specificity.

Shun-Ichi Tanaka1,2, Tetsuya Takahashi2, Akiko Koide1, Satoru Ishihara2, Satoshi Koikeda2, Shohei Koide1.   

Abstract

Current methods for engineering enzymes modify enzymes themselves and require a detailed mechanistic understanding or a high-throughput assay. Here, we describe a new approach where catalytic properties are modulated with synthetic binding proteins, termed monobodies, directed to an unmodified enzyme. Using the example of a β-galactosidase from Bacillus circulans, we efficiently identified monobodies that restricted its substrates for its transgalactosylation reaction and selectively enhanced the production of small oligosaccharide prebiotics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26322825      PMCID: PMC4989918          DOI: 10.1038/nchembio.1896

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  30 in total

1.  Target-binding proteins based on the 10th human fibronectin type III domain (¹⁰Fn3).

Authors:  Shohei Koide; Akiko Koide; Daša Lipovšek
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

Review 2.  Human milk and related oligosaccharides as prebiotics.

Authors:  Daniela Barile; Robert A Rastall
Journal:  Curr Opin Biotechnol       Date:  2013-02-19       Impact factor: 9.740

Review 3.  Strategies for the discovery and engineering of enzymes for biocatalysis.

Authors:  Timo Davids; Marlen Schmidt; Dominique Böttcher; Uwe T Bornscheuer
Journal:  Curr Opin Chem Biol       Date:  2013-03-21       Impact factor: 8.822

Review 4.  Computational enzyme design: transitioning from catalytic proteins to enzymes.

Authors:  Wai Shun Mak; Justin B Siegel
Journal:  Curr Opin Struct Biol       Date:  2014-07-05       Impact factor: 6.809

5.  Crystallographic studies of the activity of hen egg-white lysozyme.

Authors:  C C Blake; L N Johnson; G A Mair; A C North; D C Phillips; V R Sarma
Journal:  Proc R Soc Lond B Biol Sci       Date:  1967-04-18

6.  Teaching an old scaffold new tricks: monobodies constructed using alternative surfaces of the FN3 scaffold.

Authors:  Akiko Koide; John Wojcik; Ryan N Gilbreth; Robert J Hoey; Shohei Koide
Journal:  J Mol Biol       Date:  2011-12-16       Impact factor: 5.469

7.  A new bioinformatics analysis tools framework at EMBL-EBI.

Authors:  Mickael Goujon; Hamish McWilliam; Weizhong Li; Franck Valentin; Silvano Squizzato; Juri Paern; Rodrigo Lopez
Journal:  Nucleic Acids Res       Date:  2010-05-03       Impact factor: 16.971

8.  X-ray structure of cyclodextrin glycosyltransferase complexed with acarbose. Implications for the catalytic mechanism of glycosidases.

Authors:  B Strokopytov; D Penninga; H J Rozeboom; K H Kalk; L Dijkhuizen; B W Dijkstra
Journal:  Biochemistry       Date:  1995-02-21       Impact factor: 3.162

9.  A specific, highly active malate dehydrogenase by redesign of a lactate dehydrogenase framework.

Authors:  H M Wilks; K W Hart; R Feeney; C R Dunn; H Muirhead; W N Chia; D A Barstow; T Atkinson; A R Clarke; J J Holbrook
Journal:  Science       Date:  1988-12-16       Impact factor: 47.728

Review 10.  Technology prospecting on enzymes: application, marketing and engineering.

Authors:  Shuang Li; Xiaofeng Yang; Shuai Yang; Muzi Zhu; Xiaoning Wang
Journal:  Comput Struct Biotechnol J       Date:  2012-11-09       Impact factor: 7.271

View more
  11 in total

Review 1.  Harnessing glycoenzyme engineering for synthesis of bioactive oligosaccharides.

Authors:  Mounir Benkoulouche; Régis Fauré; Magali Remaud-Siméon; Claire Moulis; Isabelle André
Journal:  Interface Focus       Date:  2019-02-15       Impact factor: 3.906

2.  Targeted rescue of cancer-associated IDH1 mutant activity using an engineered synthetic antibody.

Authors:  Shahir S Rizk; Somnath Mukherjee; Akiko Koide; Shohei Koide; Anthony A Kossiakoff
Journal:  Sci Rep       Date:  2017-04-03       Impact factor: 4.379

3.  Selective Targeting of SH2 Domain-Phosphotyrosine Interactions of Src Family Tyrosine Kinases with Monobodies.

Authors:  Tim Kükenshöner; Nadine Eliane Schmit; Emilie Bouda; Fern Sha; Florence Pojer; Akiko Koide; Markus Seeliger; Shohei Koide; Oliver Hantschel
Journal:  J Mol Biol       Date:  2017-03-25       Impact factor: 5.469

Review 4.  Monobodies and other synthetic binding proteins for expanding protein science.

Authors:  Fern Sha; Gabriel Salzman; Ankit Gupta; Shohei Koide
Journal:  Protein Sci       Date:  2017-03-24       Impact factor: 6.725

5.  Biochemical Characterization of the Functional Roles of Residues in the Active Site of the β-Galactosidase from Bacillus circulans ATCC 31382.

Authors:  Huifang Yin; Tjaard Pijning; Xiangfeng Meng; Lubbert Dijkhuizen; Sander S van Leeuwen
Journal:  Biochemistry       Date:  2017-06-05       Impact factor: 3.162

6.  Protein ligands for studying ion channel proteins.

Authors:  Tanmay Chavan; Merritt Maduke; Kenton Swartz
Journal:  J Gen Physiol       Date:  2017-03-07       Impact factor: 4.086

7.  sNASP and ASF1A function through both competitive and compatible modes of histone binding.

Authors:  Andrew Bowman; Akiko Koide; Jay S Goodman; Meaghan E Colling; Daria Zinne; Shohei Koide; Andreas G Ladurner
Journal:  Nucleic Acids Res       Date:  2016-10-05       Impact factor: 16.971

8.  Engineering of the Bacillus circulans β-Galactosidase Product Specificity.

Authors:  Huifang Yin; Tjaard Pijning; Xiangfeng Meng; Lubbert Dijkhuizen; Sander S van Leeuwen
Journal:  Biochemistry       Date:  2017-01-25       Impact factor: 3.162

9.  Monobodies as possible next-generation protein therapeutics - a perspective.

Authors:  Oliver Hantschel
Journal:  Swiss Med Wkly       Date:  2017-11-20       Impact factor: 2.193

10.  Tuning SAS-6 architecture with monobodies impairs distinct steps of centriole assembly.

Authors:  Georgios N Hatzopoulos; Tim Kükenshöner; Niccolò Banterle; Tatiana Favez; Isabelle Flückiger; Virginie Hamel; Santiago Andany; Georg E Fantner; Oliver Hantschel; Pierre Gönczy
Journal:  Nat Commun       Date:  2021-06-21       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.